What it's for (Indications)
- Ethambutol (e.
- g.
- , Myambutol) is a bacteriostatic antimycobacterial agent primarily indicated for the treatment of active pulmonary and extrapulmonary tuberculosis (TB).
- It is crucial to emphasize that ethambutol is never used as a monotherapy due to the rapid development of drug resistance when administered alone.
- Instead, it is an essential component of multi-drug regimens, typically used in combination with other antitubercular agents such as isoniazid, rifampin, and pyrazinamide, especially during the initial intensive phase of treatment.
- This combination approach enhances efficacy, prevents resistance emergence, and ensures comprehensive eradication of *Mycobacterium tuberculosis*.
- Ethambutol is effective against susceptible strains of *M.
- tuberculosis* and plays a vital role in both initial treatment and re-treatment regimens for TB.
- Furthermore, it may be utilized as part of combination therapy for infections caused by atypical mycobacteria, including *Mycobacterium avium complex (MAC)* and *Mycobacterium kansasii*, when susceptibility testing supports its use.
- Its inclusion in these regimens is critical for achieving therapeutic success and minimizing the risk of treatment failure and relapse.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | General dosage and administration guidelines are not specified in the provided data. However, a dose reduction is indicated for patients with decreased renal function. |
Safety & Warnings
Common Side Effects
- The most significant and clinically important side effect associated with ethambutol is optic neuritis, which manifests as decreased visual acuity, blurred vision, central scotomas, and particularly, red-green color blindness (dyschromatopsia).
- This ocular toxicity is typically dose- and duration-dependent, necessitating baseline and regular visual acuity and color vision testing throughout the treatment course.
- While often reversible upon discontinuation of the drug, permanent visual impairment can occur.
- Patients should be advised to report any visual changes immediately.
- Other common side effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and anorexia.
- Neurological effects may include headache, dizziness, confusion, disorientation, peripheral neuropathy, and hallucinations, though these are less frequent than optic neuritis.
- Hypersensitivity reactions, including skin rash, pruritus, and fever, can also occur.
- Ethambutol can also cause hyperuricemia, leading to acute gouty arthritis, due to its interference with uric acid excretion.
- Less commonly observed adverse effects include elevated liver enzymes, leukopenia, and thrombocytopenia.
- All patients should be monitored for these potential adverse reactions to ensure safe and effective therapy.
Serious Warnings
- Black Box Warning: None
- Pregnancy: No definitive data regarding pregnancy is available; therefore, caution is advised.
- Lactation: The effects of this medication are undetermined in nursing females; consult a doctor for advice.
- Not recommended for children under thirteen years of age.
- Caution is required in patients with decreased renal function, where a dose reduction is necessary.
How it Works (Mechanism of Action)
Ethambutol exerts its bacteriostatic effect primarily by inhibiting the synthesis of the mycobacterial cell wall. Its specific target is the arabinosyl transferase enzyme, particularly EmbB, which is crucial for the polymerization of arabinan into arabinogalactan. Arabinogalactan is a unique and essential polysaccharide component of the mycobacterial cell wall, forming a complex with peptidoglycan and mycolic acids. By disrupting the activity of arabinosyl transferases, ethambutol prevents the formation of an intact arabinogalactan layer, leading to increased permeability of the cell wall. This compromised cell wall integrity impairs the growth and multiplication of susceptible *Mycobacterium tuberculosis* cells. The specificity of this mechanism to mycobacterial cell wall synthesis explains ethambutol's selective action against these organisms, with minimal impact on human cells. Its role in combination therapy is vital, as its distinct mechanism helps to prevent the emergence of resistance to other antitubercular drugs and enhances the overall bactericidal activity of the regimen. This targeted inhibition leads to structural and functional defects, ultimately hindering bacterial survival and proliferation within the host.